Prucalopride Succinate is the succinate salt form of prucalopride, an orally bioavailable dihydro-benzofuran-carboxamide and selective serotonin (5-HT4) receptor agonist, with gastrointestinal (GI) prokinetic activity. Upon oral administration, prucalopride specifically targets, binds to and stimulates the 5-HT4 receptor. This alters colonic motility patterns and stimulates colonic mass movements. This may normalize bowel movements and may relief chronic constipation. Additionally, by increasing esophageal and gastric motility, prucalopride may also provide relief for aspiration-associated symptoms. It is grouped under the following drug class(es): Prokinetic agents. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Motegrity and Resotran. Its PubChem CID is 9870009.
Prucalopride succinate
| CAS No | 179474-85-2 |
|---|---|
| Molecular Formula | C22H32ClN3O7 |
| Molecular Weight | 486.0 g/mol |
| Synonyms | 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide;butanedioic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Prucalopride Succinate is the succinate salt form of prucalopride, an orally bioavailable dihydro-benzofuran-carboxamide and selective serotonin (5-HT4) receptor agonist, with gastrointestinal (GI) prokinetic activity.
The listed CAS number is 179474-85-2.
The listed molecular formula is C22H32ClN3O7.
The listed molecular weight is 486.0 g/mol.
4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide;butanedioic acid.
The source lists Motegrity and Resotran.